An Open-Label Phase 1 Study to Examine the Effect of Multiple Doses of Rifampin on the Single-Dose Pharmacokinetics of VX 770 in Healthy Subjects.

Trial Profile

An Open-Label Phase 1 Study to Examine the Effect of Multiple Doses of Rifampin on the Single-Dose Pharmacokinetics of VX 770 in Healthy Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 06 May 2010

At a glance

  • Drugs Ivacaftor; Rifampicin
  • Indications Bacterial infections; Cystic fibrosis
  • Focus Pharmacokinetics
  • Sponsors Vertex Pharmaceuticals
  • Most Recent Events

    • 07 Jan 2010 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 12 Dec 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top